Mutations in the human δ-sarcoglycan gene in familial and sporadic dilated cardiomyopathy

Journal of Clinical Investigation

Volumn 106, Issue 5, 2000, Pages 655-662

  Tsubata, Shinichi ^a,b   Bowles, Karla R ^b   Vatta, Matteo ^b   Zintz, Carmelann ^b   Titus, Jack ^c   Muhonen, Linda ^d   Bowles, Neil E ^b   Towbin, Jeffrey A ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Jesse Edwards Cardiac Registry   (United States)

^d CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; SARCOGLYCAN;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; CYTOSKELETON; FEMALE; GENE MAPPING; GENE MUTATION; HEART DILATATION; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; SARCOLEMMA; X CHROMOSOMAL INHERITANCE;

EID: 0033818186     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI9224     Document Type: Article

References (63)

1. Dec, G.W. and Fuster, V. 1994. Idiopathic dilated cardiomyopathy. N. Engl. J. Med. 331:1564-1575.
2. Manolio, T.A., Baughman, K.L., Rodeheffer, R., Pearson, T.A., and Bristow, J.D. 1992. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute Workshop). Am. J. Cardiol. 69:1458-1466.
3. Codd, M.B., Sugrue, D.D., Gersh, B.J., and Melton, L.J. 1989. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study of Olmsted County, Minnesota, 1975-1984. Circulation. 80:564-572.
4. O'Connell, J.B., and Bristow, M.R. 1994. Economic impact of heart failure in the United States: time for a different approach. J. Heart Lung Transplant. 13:S10-S112.
5. Kasper, E.K., et al. 1994. The causes dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J. Am. Coll. Cardiol. 23:586-590.
6. Towbin, J.A. 1999. Pediatric myocardial disease. Pediatr. Clin. North. Am. 46:289-312.
7. Michels, V.V., et al. 1992. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N. Engl. J. Med. 326:77-82.
8. Keeling, P.J., et al. 1995. Familial dilated cardiomyopathy in the United Kingdom. Br. Heart J. 73:417-421.
9. Grunig, E., et al. 1998. Frequency and phenotypes of familial dilated cardiomyopathy. J. Am. Coll. Cardiol. 31:186-194.
10. Towbin, J.A. 1993. Molecular genetic aspects of cardiomyopathy. Biochem. Med. Metab. Biol. 49:285-300.
11. Bione, S., et al. 1996. A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat. Genet. 12:385-389.
12. Johnston, J., et al. 1997. Mutation characterization and genotype-phenotype correlation in Barth syndrome, Am. Hum. Genet. 61:1053-1058.
13. D'Adamo, P., et al. 1997. The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am. J. Hum. Genet. 61:862-867.
14. Bleyl, S.B., et al. 1997. Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am. J. Hum. Genet. 61:868-872.
15. Towbin, J.A., et al. 1993. X-linked dilated cardiomyopathy: molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation. 87:1854-1865.
16. Muntoni, F., et al. 1993. Brief report: deletion of the dystrophin muscle-specific promoter region associated with X-linked dilated cardiomyopathy. N. Engl. J. Med. 329:921-925.
17. Ortiz-Lopez, R., Li, H., Su, J., Goytia, V., and Towbin, J.A. 1997. Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation. 95:2434-2440.
18. Durand, J.B., et al. 1995. Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32. Circulation. 92:3387-3389.
19. Siu, B.L., et al. 1999. Familial dilated cardiomyopathy locus maps to chromosome 2q31. Circulation. 99:1022-1026.
20. Krajinovic, M., et al. 1995. Linkage of familial dilated cardiomyopathy to chromosome 9. Am. J. Hum. Genet. 57:846-852.
21. Bowles, K.R., et al. 1996. Gene mapping of Famalial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. J. Clin. Invest. 98:1355-1360.
22. Olson, T.M., Michels, V.A., Thibodeau, S.N., Tai, Y.S., and Keating, M.T. 1998. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science. 280:750-752.
23. Kass, S., et al. 1994. A genetic defect that causes conduction system disease and dilated cardiomyopathy maps to 1p1-1q1. Natl. Genet. 7:546-551.
24. Jung, M., et al. 1999. Investigation of a family with autosomal dominant dilated cardiomyopathy defines a novel locus on chromosome 2q14-q22. Am. J. Hum. Genet. 65:1068-1077.
25. Li, D., et al. 1999. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation. 100:461-464.
26. Olson, T.M., and Keating, M.T. 1996. Mapping a cardiomyopathy locus to chromosome 3p22-p25. J. Clin. Invest. 97:528-532.
27. Messina, D.N., Speer, M.C., Pericak-Vance, M.A., and McNally, E.M. 1997. Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23. Am. J. Hum. Genet. 61:909-917.
28. Fatkin, D., et al. 1999. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction system disease. N. Engl. J. Med. 341:1715-1724.
29. Towbin, J.A., Bewies, K.R., and Bowles, N.E. 1999. Etiologies of cardiomyopathy and heart failure. Nat. Med. 3:266-267.
30. Towbin, J.A. 1998. The role of cytoskoletal proteins in cardiomyopathy. Curr. Opin. Cell. Biol. 10:131-139.
31. Bonne, G., Carrier, L., Richard, P., Hainque, B., and Schwartz, K. 1998. Familial hypertrophic cardiomyopathy: from mutations to functional defects. Circ. Res. 83:580-593.
32. Wang, Q., Bowles, N.E., and Towbin, JA 1998. The molecular basis of long QT syndrome and prospects for therapy. Mol. Med. Today. 4:382-388.
33. Bajusz, E., Baker, J.R., Nixon, C.W., and Homburger, F. 1969. Spontaneous, hereditary myocardial degeneration and congestive heart failure in a strain of Syrian hamsters. Ann NY Acad. Sci. 156:105-129.
34. Homburger, F. 1979. Myopathy of hamster dystrophy: history and morphologic aspects. Ann. NY Acad. Sci. 317:1-17.
35. Sakamoto A., et al. 1997. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, δ-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc. Natl. Acad. Sci. USA. 94:13873-13878.
36. Nigro, V., et al. 1997. Identification of the Syrian hamster cardiomyopathy gene. Hum. Mol. Genet. 6:601-607.
37. Sakamoto, A., Abe, M., and Masaki, T. 1999. Delineation of genomic deletion in cardiomyopathic hamster. FEBS Lett. 447:124-128.
38. Straub, V. 1998. Molecular pathogenesis of muscle degeneration in the delta-sarcoglycan-deficient hamster. Am. J. Pathol. 153:1623-1630.
39. Nigro, V., et al. 1996. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat. Genet. 14:195-198.
40. Moreira, E.S., et al. 1998. A first missense mutation in the delta sarcoglycan gene associated with a severe phenotype and frequency of limbgirdle muscular dystrophy type 2F (LGMD2F) in Brazilian sarcoglycanopathies. J. Med. Genet. 35:951-953.
41. Melacini, P., et al. 1999. Heart involvement in muscular dystrophies due to sarcoglycan gene mutations. Muscle Nerve. 22:473-479.
42. Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., and Sekiya, T. 1989. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA. 86:2766-2770.
43. Garmier J., Osguthorpe, D.J., and Robson, B. 1978. Analyses of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J. Biol. Chem. 120:97-120.
44. Nigro, V., et al. 1996. Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein. Hum. Mol. Genet. 5:1179-1186.
45. Jung, D., et al. 1996. Characterization of delta-sarcoglycan, a novel component of the oligomeric sarcoglycan complex involved in limb-girdle muscular dystrophy. J. Biol. Chem. 271:32321-32329.
46. Bender, J.R. 1991. Idiopathic dilated cardiomyopathy. An immunologic, genetic, or infectious disease, or all of the above? Circulation. 83:515-522.
47. Mogensen, J., et al. 1999. α-cardiac actin is a novel gene in familial hypertrophic cardiomyopathy. J. Clin. Invest. 103:R39-R43.
48. Towbin, J.A. 1999. Towards an understanding of the cause of mitral valve prolapse. Am. J. Hum. Genet. 65:1238-1241.
49. Hoffman, E.P., Brown, R.H., and Kunkel, L.M. 1987. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 51:919-928.
50. Lim, L.E., and Campbell, K.P. 1998. The sarcoglycan complex in limb-girdle muscular dystrophy. Curr. Opin. Neurol. 11:443-452.
51. Matsumura, K., et al. 1999. Sarcoglycan complex: a muscular supporter of dystroglycan-dystrophin interplay? Cell. Mol. Biol. 45:751-762.
52. Towbin, J.A. 1995. Biochemical and molecular characterization of X-linked dilated cardiomyopathy (XLCM). In Developmental mechanisms of heart disease. E.B. Clark, R.R. Markwald, and A. Takao, editors, Futura Publishing Co. New York, New York, USA. 121-132.
53. Nowak, K.J., et al. 1999. Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy. Nat. Genet. 23:208-212.
54. Bonne, G., et al. 1999. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat. Genet. 21:285-288.
55. Raffaele Di Barletta, M., et al. 2000. Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am. J. Hum. Genet. 66:1407-1412.
56. Nigro, V., et al. 1996. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat. Genet. 14:195-198.
57. Duggan, D.J., et al. 1997. Mutations in the delta-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2). Neurogenetics. 1:49-58.
58. Muchir, A., et al. 2000. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum. Mol. Genet. 9:1453-1459.
59. Minetti, C., et al. 1998. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat. Genet. 18:365-368.
60. Hack, A.A., et al. 1998. Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J. Cell. Biol. 142:1279-1287.
61. Coral-Vazquez, R., et al. 1999. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell. 98:465-474.
62. Gnecchi-Ruscone, T., et al. 1999. Cardiomyopathy in Duchenne, Becker, and sarcoglycanopathies: a role for coronary dysfunction? Muscle Nerve. 22:1549-1556.
63. Araishi, K., et al. 1999. Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice. Hum. Mol. Genet. 8:1589-1598.